Introduction {#S0001}
============

Opium and opioids have been used since ancient times to relieve pain, which is one of the major signs of inflammation,[@CIT0001] and currently they are the most commonly used drug for pain relief.[@CIT0002] It has been shown that opioid-mediated analgesia is mainly elicited via activation of peripheral opioid receptors,[@CIT0003] and anti-inflammatory actions of opioids, in addition to their analgesic effects, are produced through attenuation of the release of excitatory proinflammatory neuropeptides from peripheral nociceptors.[@CIT0003]--[@CIT0005] However, it has also been reported that, in contrast to their anti-inflammatory actions, opioids interact with opioid receptors on the membranes of immune cells and alter cytokine production, ultimately inducing a pro-inflammatory state.[@CIT0006] A clinically useful marker that reflects such opioid-induced pro-inflammatory actions is elevated C-reactive protein (CRP).[@CIT0006],[@CIT0007]

CRP is a protein produced by the liver, and its level increases in response to inflammation[@CIT0008] Several studies have reported that CRP levels may be elevated in opioid-induced pro-inflammatory states.[@CIT0007],[@CIT0009],[@CIT0010] Moreover, a recent cohort study has reported that compared to non-opioid users, plasma CRP level was elevated in opioid users.[@CIT0011] Similarly, several lines of evidence suggest a correlation between opioid dosage and CRP level. In addition, associations between CRP levels and surgical stress and postoperative recovery have been recently reported.[@CIT0012] Accordingly, CRP levels may be associated with patients' postoperative opioid requirements and pain scores, and correlations may exist between perioperative CRP levels and an increase in CRP levels, and a patient's opioid analgesic requirements and severity of postoperative pain. However, there is only limited information available regarding these possible correlations.

Thus, the present study aimed to measure the association between perioperative CRP levels and postoperative opioid analgesic requirements and pain scores of patients who underwent major laparoscopic abdominal surgery. We hypothesized that patients' postoperative opioid requirements and pain scores would be positively associated with preoperative and postoperative CRP levels, and increases of CRP levels.

Material and methods {#S0002}
====================

This retrospective cohort study was approved by the Institutional Review Board (IRB) of Seoul National University Bundang Hospital (approval number: B-1803/459-105, approval date: March 12, 2018). The need for informed consent was waived by the IRB owing to the retrospective nature of the study, and this study followed the Declaration of Helsinki in confidentiality of patient data. Demographic, clinical, and surgery-related information of patients was collected. All medical records were collected by a medical record technician who was blinded to the study.

Patients {#S0002-S2001}
--------

The medical records of patients aged 20 years or older who received an elective major laparoscopic abdominal surgery from January 1, 2010 to December 31, 2016 were collected for retrospective analysis. A major laparoscopic abdominal surgery was defined as all laparoscopy-guided surgical procedures involving intraperitoneal organ resection lasting over 2 h. However, simple appendectomy and cholecystectomy were excluded even if they lasted more than 2 h. Since these major laparoscopic abdominal surgeries include a heterogeneous population, many cases were excluded to analyze a relatively homogenous population regarding postoperative pain outcomes. These exclusion criteria were as follows: 1) patients who underwent emergency surgery; 2) patients who underwent single-port laparoscopy; 3) patients who were released before postoperative day (POD) 3; 4) patients who underwent an additional surgery during POD 0--3; 5) patients who needed intraoperative open conversion; and 6) patients who received continuous infusion of remifentanil or dexmedetomidine for pain control or sedation in the intensive care unit (ICU) on POD 0--3. No patients received continuous infusion of remifentanil or dexmedetomidine in the ward during POD 0--3; all patients requiring sedation in the postoperative period were admitted to ICU after surgery.

Surgical resection of major intraperitoneal organs (liver,[@CIT0013] stomach,[@CIT0014] colon and rectum,[@CIT0015] and pancreas[@CIT0016]) were performed by experienced surgical teams during the study period. For this study, surgeries were divided into five groups according to the main resected organ during surgery: upper gastrointestinal tract (stomach, duodenum, and small bowel); lower gastrointestinal tract (colon and rectum); hepatobiliary-pancreas-spleen; uterus-ovary; and prostate-kidney-bladder.

Anesthesia and analgesia for major laparoscopic abdominal surgery {#S0002-S2002}
-----------------------------------------------------------------

All patients were anesthetized using two methods: one is remifentanil-inhalation agent (desflurane or sevoflurane) balanced anesthesia, and the other is total intravenous anesthesia (TIVA) with remifentanil-propofol.

Most patients received intravenous (IV) patient-controlled analgesia (PCA) on POD 0-2 after surgery. IV PCA was prepared with 8--12 mcg of fentanyl per 1 mL of normal saline (total 100 ml) and set at a background infusion rate of 0.8--1.2 mL h^−1^ and bolus dose of 0.5--1.5 mL depending on the patient's underlying painful conditions and age. Additional opioid analgesics (eg, oxycodone, morphine, and fentanyl) were prescribed for most patients based on the physician's prescription and the patients' need. Adjuvant analgesics (acetaminophen and ketorolac) were also used for additional pain control. In general, local anesthetic infiltration into the wound sites was not performed during the study period.

Collection of perioperative CRP data {#S0002-S2003}
------------------------------------

At the institution, CRP level (mg dL^−1^) is measured for patients undergoing elective surgery as part of the preoperative routine laboratory test within one month prior to the surgery. We defined this CRP level as the preoperative CRP. A patient's CRP level is also measured during POD 0--3 after surgery, depending on the type of surgical procedure the patient received and the surgeon's decision. The highest CRP level measured during POD 0--3 after surgery was defined as the postoperative CRP level. The difference between the postoperative CRP and preoperative CRP levels was defined as the increase of CRP.

Postoperative pain outcomes on POD 0--3 {#S0002-S2004}
---------------------------------------

Pain scores were measured every 4--6 h at least 4 times a day on a numeric rating scale (NRS), with scores ranging from 0 to 10, by registered nurses. The mean NRS pain scores obtained on POD 0, 1, 2, and 3 were defined as the NRS pain score of the corresponding POD (POD 0, 1, 2, and 3). The total amount of opioid used, including the POD 0--3 IV PCA and additional opioid analgesics, was measured and summed up using oral morphine equivalent consumption (mg). A standard conversion ratio was used for the conversion and calculation[@CIT0017] The data on the amount of oral acetaminophen (mg) and IV ketorolac (mg) used during POD 03 were additionally collected ([Table S1](#ST0001)).

Outcome {#S0002-S2005}
-------

This study aimed to measure the associations between preoperative, postoperative, and increase of CRP levels and patients' postoperative pain outcome (morphine equivalent consumption in 0--3, NRS pain score on POD 0--3, and adjuvant analgesics use on POD 0--3) following a major laparoscopic abdominal surgery. Additionally, we investigate whether this association was different according to anesthetic management (inhalation or TIVA)

Statistical analysis {#S0002-S2006}
--------------------

The baseline characteristics of the patients are presented either as a number with percentage or mean value with SD. Restricted cubic splines (RCSs) were used to assess the log odds of morphine equivalent consumption on POD 0--3 according to the patients' preoperative, postoperative, and increase of CRP levels. First, we examined the normality of distribution in dependent variables, such as morphine equivalent consumption, NRS on POD 0--3, acetaminophen consumption, and ketorolac consumption, by Kolmogorov--Smirnov test. After confirming that these variables did not follow a normal distribution, we decided to perform generalized linear regression analysis. In this generalized linear regression model, a gamma distribution was assumed for the dependent variable (morphine equivalent consumption), and a log link function was used. In this multivariate generalized linear regression analysis, all covariates were included for adjustment. Multicollinearity among variables was taken into account, and we established two multivariate generalized linear regression models, one for preoperative and postoperative CRP levels and the second for increase in CRP (postoperative CRP -- preoperative CRP). In addition, another multivariate generalized linear regression analysis was performed for six postoperative outcomes (NRS pain score on POD 0--3, acetaminophen, and ketorolac use on POD 0--3) as dependent variables using the same manner. Additionally, we performed two subgroup analyses according to anesthetic management for major laparoscopic abdominal surgery (TIVA and inhalation group). The results of each analysis are presented as exponentiated regression (Exp) coefficients and 95% CI. All data were analyzed using IBM SPSS 24.0 (IBM Corp., Armonk, NY, USA) and statistical significance was set at *P*\<0.05. For the subgroup analysis (TIVA and inhalation group), we performed Bonferroni correction to control type 1 error in multiple comparisons,[@CIT0018] and a Bonferroni-corrected *P*\<0.025 was considered to indicate statistical significance.

Results {#S0003}
=======

A total of 20,800 patients underwent laparoscopy guided surgical procedures from January 2010 to December 2016. Of those patients, the following patients were excluded from the analysis: 1) patients under 20 years of age (856); 2) patients who underwent emergency surgery (1,053); 3) patients who underwent single port laparoscopy (1,390); 4) surgical procedures under 2 h (9,571); 5) patients who received continuous infusion of remifentanil or dexmedetomidine in the ICU on POD 0--3 (343); 6) patients who were released within 3 days after surgery (8); 7) patients who underwent additional procedures during POD 0--3 (25); 8) patients who needed intraoperative open conversion (42); 9) patients who underwent a simple appendectomy or cholecystectomy \>2 h (96); and 10) patients with missing or incomplete medical record regarding CRP (2,763). The final sample of 4,653 patients was included in the analysis ([Figure 1](#F0001){ref-type="fig"}). The characteristics of these patients are shown in [Table 1](#T0002){ref-type="table"}. The mean (SD) preoperative CRP level (mg dL^−1^), the mean postoperative CRP level, and the increase of CRP level were 3.5 (5.0), 9.7 (5.6), and 6.2 (6.6), respectively.Table 1Characteristics of patients who received major laparoscopic abdominal surgery in 2010--2016VariablesTotal (n=4,653)Mean (SD)Age, year60.1 (12.7)Body mass index, kg m^−2^24.1 (3.4)Sex: male/female2,950/1,703 (63.4%/36.6%)Preoperative comorbidites ASA class 11,813 (39.0%) 22,658 (57.1%) ≥ 3182 (3.9%) Hypertension1,463 (31.4%) Diabete mellitus722 (15.5%) Ischemic heart disease210 (4.5%) Cerebrovascular disease130 (2.8%) Chronic kidney disease68 (1.5%) Cancer3,924 (84.3%)Information regarding surgical procedures Surgery time, min200.1 (69.8) Mainly resected organ during surgery  Upper gastrointestinal tract2,152 (46.2%)  Lower gastrointestinal tract1,920 (41.3%)  Hepato-biliary-panreas-spleen474 (10.2%)  Uterus-ovary32 (0.7%)  Prostate-kidney-bladder75 (1.6%) Propofol based intravenous anesthesia735 (15.8%) Intraoperative magnesium sulfate infusion387 (8.3%) Length of hospital stay after surgery, day7.7 (7.0) Years at surgery  2010-20121,287 (27.7%)  2013-20141,254 (27.0%)  2015-20162,112 (45.4%)Postoperative analgesics consumption on PODs 0-3 Oral morphine equivalent consumption, mg592.20 (282.39) Acetaminophen, mg336.73 (785.55) Ketorolac, mg14.10 (106.01)Numeric rating scale, pain score POD 05.4 (1.5) POD 14.6 (1.1) POD 23.8 (1.0) POD 33.2 (1.0)Preoperative CRP, mg dl^−1^3.5 (5.0)Postoperative CRP, mg dl^−1^9.7 (5.6)Increase of CRP, mg dl^−1^6.2 (6.6)[^1] Figure 1Flowchart for patient selection; 16,147 patients were excluded in the final analysis due to 10 causes.**Abbreviation:** POD, postoperative day.

Morphine equivalent consumption on POD 0--3 {#S0003-S2001}
-------------------------------------------

Log odds of morphine equivalent consumption on POD 0--3 by preoperative CRP (A), postoperative CRP (B), and increase of CRP (C) levels are plotted as RCS in [Figure 2](#F0002){ref-type="fig"}. Log odds of morphine equivalent consumption by preoperative CRP levels first decreases and then increases, whereas log odds of morphine equivalent consumption by postoperative CRP levels and increase of CRP levels gradually increase with increasing level of CRP.Figure 2Relationship between morphine equivalent consumption on POD 0--3, and preoperative CRP **(A)**, postoperative CRP **(B)**, and increase of CRP **(C)** levels. Increase of CRP (mg dL^−1^): postoperative CRP -- preoperative CRP.**Abbreviations:** POD, postoperative day; CRP, C-reactive protein.

The results of multivariate generalized linear regression analysis including all covariates are shown in [Table 2](#T0003){ref-type="table"}. In multivariate model 1, an increase of 1 mg dL^−1^ of postoperative CRP level was significantly associated with an 1.4% increase morphine equivalent consumption \[Exp coefficient: 0.014, 95% CI (0.011, 0.016), *P*\<0.001\], whereas preoperative CRP levels were not significantly associated with morphine equivalent consumption on POD 0--3 (*P*=0.450). In multivariate model 2, an 1 mg dL^−1^ increase of CRP level was significantly associated with an 1.0% increase morphine equivalent consumption \[Exp coefficient: 0.010, 95% CI (0.008, 0.012), *P*\<0.001\].Table 2Multivariate generalized linear regression analysis for morphine equivalent (mg) consumption in POD 0--3 after major laparoscopic abdominal surgery in 2010--2016VariablesExp. Coefficient (95% CI)*P*-valueAge, year-0.010 (-0.011, -0.008)\<0.001Sex: male (vs Female)0.114 (0.086, 0.141)\<0.001Body mass index, kg m^−2^0.018 (0.014, 0.022)\<0.001ASA 2 (vs 1)0.005 (-0.028, 0.038)0.762 ≥ 3 (vs 1)0.036 (-0.040, 0.112)0.350Preoperative Comorbidity Hypertension0.008 (-0.025, 0.042)0.622 Diabetes mellitus0.006 (-0.032, 0.045)0.740 Ischemic heart disease0.016 (-0.048, 0.080)0.618 Cerebrovascular disease-0.018 (-0.098, 0.061)0.650 Chronic kidney disease-0.076 (-0.184, 0.031)0.164 Cancer0.116 (0.078, 0.154)\<0.001Surgery time, min0.001 (0.001, 0.001)\<0.001Mainly resected organ during surgery Lower gastrointestinal tract (vs UGI tract)0.086 (0.057, 0.116)\<0.001 Hepato-biliary-panreas-spleen (vs UGI tract)-0.373 (-0.421, -0.325)\<0.001 Uterus-ovary (vs UGI tract)-0.623 (-0.789, -0.457)\<0.001 Prostate-kidney-bladder (vs UGI tract)-0.210 (-0.316, -0.105)\<0.001Propofol based intravenous anesthesia-0.106 (-0.150, -0.062)\<0.001Intraoperative magnesium sulfate infusion0.065 (-0.001, 0.132)0.054Years of surgery 2013-2014 (vs 2010-2012)0.171 (0.136, 0.207)\<0.001 2015-2016 (vs 2010-2012)0.245 (0.212, 0.277)\<0.001Preperative CRP, mg dl^−1^ (model 1)-0.001 (-0.004, 0.002)0.450Postoperative CRP, mg dl^−1^ (model 1)**0.014** (0.011, 0.016)**\<0.001**Increase of CRP, mg dl^−1^ (model 2)**0.010** (0.008, 0.012)**\<0.001**[^2]

NRS pain score on POD 0--3 and adjuvant analgesics use on POD 0--3 {#S0003-S2002}
------------------------------------------------------------------

The results of multivariate generalized linear regression analysis of NRS pain scores on POD 0--3 and acetaminophen and ketorolac use on POD 0--3 are shown in [Table 3](#T0004){ref-type="table"}. Postoperative CRP levels were positively associated with NRS pain scores on POD 1 \[Exp coefficient: 0.003, 95% CI (0.001, 0.004), *P*\<0.001\], NRS pain scores on POD 2 \[Exp coefficient: 0.006, 95% CI (0.004, 0.007), *P*\<0.001\], and NRS pain scores on POD 3 \[Exp coefficient: 0.007, 95% CI (0.005, 0.009), *P*\<0.001\]. Increase of CRP levels were positively associated with NRS pain scores on POD 0 \[Exp coefficient: 0.001, 95% CI (0.000, 0.003), *P*=0.049\], POD 1 \[Exp coefficient: 0.002, 95% CI (0.001, 0.003), *P*\<0.001\], POD2 \[Exp coefficient: 0.004, 95% CI (0.002, 0.005), *P*\<0.001\], and POD3 \[Exp coefficient: 0.004, 95% CI (0.002, 0.005), *P*\<0.001\]. Preoperative and postoperative CRP, and increase of CRP levels were not significantly associated with acetaminophen and ketorolac use on POD 0--3 (*P*\>0.05).Table 3Multivariate generalized linear regression for NRS pain score at rest on POD 0--3 and adjuvant analgesics use after major laparoscopic abdominal surgery in 2010--2016VariablesExp. Coefficient (95% CI)*P*-valueNRS pain score on POD 0 Preperative CRP, mg dl^−1^ (model 1)-0.002 (-0.003, 0.000)0.085 Postoperative CRP, mg dl^−1^ (model 1)0.001 (0.000, 0.003)0.136 Increase of CRP, mg dl^−1^ (model 2)0.001 (0.000, 0.003)0.049NRS pain score on POD 1 Preperative CRP, mg dl^−1^ (model 1)-0.002 (-0.003, 0.000)0.059 Postoperative CRP, mg dl^−1^ (model 1)0.003 (0.001, 0.004)\<0.001 Increase of CRP, mg dl^−1^ (model 2)0.002 (0.001, 0.003)\<0.001NRS pain score on POD 2 Preperative CRP, mg dl^−1^ (model 1)-0.001 (-0.003, 0.000)0.145 Postoperative CRP, mg dl^−1^ (model 1)0.006 (0.004, 0.007)\<0.001 Increase of CRP, mg dl^−1^ (model 2)0.004 (0.002, 0.005)\<0.001NRS pain score on POD 3 Preperative CRP, mg dl^−1^ (model 1)0.000 (-0.002, 0.002)0.800 Postoperative CRP, mg dl^−1^ (model 1)0.007 (0.005, 0.009)\<0.001 Increase of CRP, mg dl^−1^ (model 2)0.004 (0.002, 0.005)\<0.001Acetaminophen (mg) use in POD 0-3Preperative CRP, mg dl^−1^ (model 1)-0.010 (-0.018, 0.003)0.129 Postoperative CRP, mg dl^−1^ (model 1)0.004 (-0.001, 0.008)0.058 Increase of CRP, mg dl^−1^ (model 2)0.006 (-0.003, 0.015)0.157Ketorolac use (mg) in POD 0-3 Preperative CRP, mg dl^−1^ (model 1)0.005 (-0.013, 0.024)0.555 Postoperative CRP, mg dl^−1^ (model 1)-0.021 (-0.039, 0.007)0.251 Increase of CRP, mg dl^−1^ (model 2)-0.016 (-0.030, 0.020)0.532[^3]

Subgroup analysis according to anesthetic management {#S0003-S2003}
----------------------------------------------------

The results of multivariate generalized linear regression analysis for morphine equivalent (mg) consumption in POD 0--3 according to anesthetic management are presented in [Table 4](#T0005){ref-type="table"}. A 1 mg dL^−1^ increase of postoperative CRP is associated with increase of morphine equivalent consumption on POD 0--3 in both inhalation group \[Exp coefficient: 0.012, 95% CI (0.009, 0.015), *P*\<0.001\] and TIVA group \[Exp coefficient: 0.010, 95% CI (0.003, 0.017), *P*=0.004\]. A 1 mg dL^−1^ increase of CRP is associated with increase of morphine equivalent consumption on POD 0--3 in only the inhalation group \[Exp coefficient: 0.011, 95% CI (0.008, 0.013), *P*\<0.001\].Table 4Multivariate generalized linear regression analysis for morphine equivalent (mg) consumption in POD 0--3 after major laparoscopic abdominal surgery in 2010--2016 according to anesthetic managementVariablesExp. Coefficient (95% CI)*P*\*Inhalation group (n=3,918) Preperative CRP, mg dl^−1^ (model 1)-0.002 (-0.005, 0.001)0.185 Postoperative CRP, mg dl^−1^ (model 1)0.012 (0.009, 0.015)\<0.001 Increase of CRP, mg dl^−1^ (model 2)0.011 (0.008, 0.013)\<0.001Propofol based TIVA (n=735) Preperative CRP, mg dl^−1^ (model 1)0.006 (-0.003, 0.014)0.180 Postoperative CRP, mg dl^−1^ (model 1)0.010 (0.003, 0.017)0.004 Increase of CRP, mg dl^−1^ (model 2)0.005 (-0.001, 0.011)0.085[^4][^5]

Discussion {#S0004}
==========

The present study showed that morphine equivalent consumption on POD 0--3 following a major laparoscopic abdominal surgery is positively associated with postoperative CRP and an increase of CRP levels. The patients' NRS pain scores were also positively associated with postoperative CRP levels (on POD 1--3) and increase of CRP levels (on POD 2--3). These results not only add to the findings of previous studies that showed CRP level is a clinical marker related to postoperative recovery,[@CIT0012],[@CIT0019] but also show CRP level may reflect postoperative pain outcome.

The positive association between postoperative CRP and increase of CRP levels and the patients' opioid consumptions and pain scores on POD 0--3 may be attributed to several causes. First, postoperative CRP level is an indicator reflecting the invasiveness of a surgical procedure.[@CIT0020] Surgical stress from relatively more invasive procedures has been reported to induce more severe postoperative pain.[@CIT0021] Second, the elevated CRP level during the postoperative period is known to be closely associated with major postoperative complications, including infections.[@CIT0022],[@CIT0023] Postoperative pain may be both the cause and result of postoperative complication,[@CIT0024] and elevated CRP level may be a useful clinical marker reflecting this relationship. Furthermore, postoperative CRP could predict the severity of postoperative complications.[@CIT0025] Although our study focused on only laparoscopic surgery, it was reported that elevated CRP levels could be used as a marker for major postoperative complication in both open and minimally invasive surgery.[@CIT0023] Therefore, there was a possibility that postoperative complications affected severe postoperative pain with elevated CRP levels in this study.

From a different perspective, the association between postoperative opioid consumption and inflammation may be due to desensitization. Opioid receptors are members of the G-protein coupled receptor family, and the activation of an opioid receptor may decrease the activation of chemokine receptors.[@CIT0006],[@CIT0026] This desensitization may increase inflammatory cytokines, including CRP, and this process may be seen as a homeostatic response. In contrast, inflammation reaction from surgical stress may induce higher use of opioids. The patients with relatively higher surgical stress have a greater inflammatory reaction, and subsequently require a greater amount of opioid therapy. Lastly, opioids have been reported to induce pro-inflammatory reactions in in vitro studies,[@CIT0027],[@CIT0028] and a recent cross-sectional cohort study showed that an elevated CRP level is associated with opioid prescription.[@CIT0011] However, evidence on the association between opioid use and CRP level is still limited and this needs further investigation.

The results of subgroup analysis according to anesthetic management was also notable in this study. Although postoperative CRP level was associated positively with opioid consumption in POD 0--3, increase of CRP was only associated with opioid consumption in the inhalation group. There was a possible reason that propofol-based TIVA suppresses the inflammatory response caused by surgery, compared to the balanced inhalation technique.[@CIT0029] This effect could be explained by the anti-inflammatory effect of propofol.[@CIT0030] Considering that CRP increases in response to inflammation,[@CIT0008] increase of CRP during surgery could be attenuated in the propofol-based TIVA group, resulting in a lower effect on postoperative opioid consumption in the TIVA group than in the inhalation group.

The present study suggests the importance of postoperative management for patients who undergo major abdominal laparoscopic surgery. Patients with elevated CRP level during the postoperative period require a more careful pain control regimen. Thus, measuring postoperative CRP levels may help predict the possibility of severe pain in patients, and the use of regional analgesic techniques and adjuvant analgesics may be considered for patients with elevated postoperative CRP levels. Moreover, our findings suggest that a decrease in postoperative CRP levels is closely associated with postoperative pain intensity and opioid requirement of patients. Lastly, minimizing postoperative CRP elevation through more minimally invasive surgical procedures is important to reduce the length of stay[@CIT0012],[@CIT0023] and for lower postoperative pain.

This study has several limitations. First, like all retrospective cohort designs, this study may have involved selection bias. We tried to circumvent this limitation by having a medical record technician blinded to the study's purpose collect data used for the analysis. Second, the generalizability may be limited as this was a single-center study. Third, although fentanyl-based IV PCA was the main source of opioid analgesia, additional opioids were also used by the patients. Thus, a standard conversion ratio was needed for comparison of these analgesics. Fourth, a number of registered nurses were involved in collecting patients' pain score data over the 7-year study period. Therefore, the accuracy of NRS pain scores may not be completely guaranteed. Fifth, we did not evaluate the postoperative complication in this study, which could affect both postoperative CRP levels and opioid consumption. Lastly, we did not evaluate other inflammatory cytokines such as interleukin, procalcitonin, or tumor necrosis factors in this study. Nevertheless, our study demonstrates for the first time the association between postoperative CRP levels and postoperative pain outcome.

Conclusion {#S0005}
==========

This study showed postoperative CRP and increase of CRP levels are positively associated with opioid consumption and higher pain scores after a major laparoscopic abdominal surgery.
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Table S1Equianalgesic opioid conversion tableOpioidAdministration routeDose equivalent to 10 mg of oral morphine (mg)MorphineOral10MorphineIntravenous3.3HydromorphoneOral2FentanylIntravenous0.03OxycodoneOral7CodeineOral80TramadolOral40

[^1]: **Note:** Presented as number with percentage or mean value with SD.

    **Abbreviations:** SD, standard deviation; ASA, American Society of Anesthesiologists; POD, postoperative day; CRP, C-reactive protein.

[^2]: **Abbreviations:** POD, postoperative day; Exp, exponentiated regression; CI, confidence interval; ASA, American Society of Anesthesiologists; UGI, upper gastrointestinal tract; CRP, C-reactive protein.

[^3]: **Note:** All covariates were included for adjustment in each multivariate generalized linear models.

    **Abbreviations:** NRS, numeric rating scale; POD, postoperative day; Exp, exponentiated regression; CI, confidence interval; CRP, C-reactive protein.

[^4]: **Note:** *\*P*\<0.025 was considered to indicate statistical significance after Bonferroni correction. All covariates were included for adjustment in each multivariate generalized linear models.

[^5]: **Abbreviations:** POD, postoperative day; Exp, exponentiated regression; CI, confidence interval; CRP, C-reactive protein; TIVA, total intravenous anesthesia.
